Lenshil Capsules contain lenvatinib, an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. Lenshil is prescribed for specific types of cancer and should only be used under the supervision of a qualified oncologist or healthcare professional. Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical supplier and exporter supporting hospitals, pharmacies, healthcare institutions, distributors and licensed importers seeking oncology medicines for international markets, including South Africa. Lenshil Capsules – Product Description Lenshil contains lenvatinib, which works by inhibiting specific receptor tyrosine kinases involved in pathways that support tumour growth and the formation of new blood vessels. By interfering with these signalling pathways, lenvatinib can help slow the progression of certain cancers. Depending on the patient's diagnosis and treatment plan, lenvatinib may be prescribed for conditions including differentiated thyroid cancer, hepatocellular carcinoma (liver cancer), renal cell carcinoma in combination treatment, and certain endometrial cancers. The appropriate indication, dose and treatment duration must be determined by the treating healthcare professional. Patients should not start, stop or change Lenshil dosage without medical advice. Lenvatinib treatment can require monitoring for blood pressure, kidney and liver function and other potential treatment-related effects. Lenshil Capsules Strengths Lenshil is available in different strengths of lenvatinib. Availability can vary according to market and supply requirements. Lenshil 4 mg Capsules Lenshil 10 mg Capsules Lenshil 12 mg Capsules Lenshil 18 mg Capsules Lenshil 24 mg Capsules The 4 mg and 10 mg strengths are documented in South African prescribing information for lenvatinib, while additional Lenshil strengths have been introduced in India. The strength selected for an individual patient depends on the cancer type, treatment regimen, clinical condition and the oncologist's prescription. Patients should never select a strength based solely on online information. Lenshil Capsules for South Africa For customers searching for Lenshil Capsules in South Africa, Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and supply support from India. Product availability, documentation, import requirements and shipment arrangements depend on the destination country's applicable pharmaceutical regulations. As lenvatinib is a prescription oncology medicine, patients should obtain it through appropriate healthcare and pharmacy channels and use it only as prescribed. Why Choose Cordium Pharmaceuticals Pvt Ltd? India-based pharmaceutical supplier and exporter Focus on oncology and specialty medicines Support for hospitals, pharmacies and licensed distributors International pharmaceutical shipment assistance Export documentation support subject to destination requirements Product and quotation assistance for eligible business enquiries Frequently Asked Questions 1. What is Lenshil Capsule used for? Lenshil contains lenvatinib and may be prescribed for certain cancers, including differentiated thyroid cancer, liver cancer, kidney cancer in combination treatment and some endometrial cancers. 2. What are the available Lenshil strengths? Lenshil strengths include 4 mg, 10 mg, 12 mg, 18 mg and 24 mg in markets where these presentations are approved and available. 3. Is Lenshil a prescription medicine? Yes. Lenvatinib is a prescription oncology medicine and should be taken only according to the instructions of a qualified healthcare professional. South African prescribing information identifies lenvatinib as a Schedule 4 medicine. 4. Can Lenshil be taken with food? Lenvatinib may generally be taken with or without food, at approximately the same time each day. Follow the specific instructions provided by the prescribing healthcare professional. 5. What are common side effects? Possible adverse effects include high blood pressure, diarrhoea, nausea, fatigue, decreased appetite, headache and bleeding. Patients should contact their healthcare professional if side effects are severe, persistent or concerning. 6. Can Cordium Pharmaceuticals supply Lenshil to South Africa? Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply enquiries from India. Availability and shipment are subject to applicable South African import, prescription and regulatory requirements.

Triumeq tablets are a fixed-dose combination medicine containing abacavir, dolutegravir and lamivudine. It is used as part of antiretroviral treatment for HIV-1 infection. Combining three active ingredients into one tablet can provide a convenient once-daily treatment option when prescribed as appropriate by a qualified healthcare professional. For patients, pharmacies, healthcare providers and pharmaceutical buyers searching for Triumeq tablets in South Africa, Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical supply and export assistance from India, subject to applicable prescription, import and regulatory requirements. Triumeq Tablets – Composition and Strength The standard Triumeq tablet contains: Abacavir 600 mg Dolutegravir 50 mg Lamivudine 300 mg The combination works through different mechanisms involved in HIV replication. Dolutegravir is an integrase inhibitor, while abacavir and lamivudine belong to the nucleoside reverse transcriptase inhibitor class. Triumeq Tablets Uses Triumeq is indicated for the treatment of HIV-1 infection in appropriate patients. Treatment should be selected and monitored by a healthcare professional based on the patient's medical history, treatment response, resistance profile, kidney and liver function, and other medicines being taken. Before treatment containing abacavir is started, HLA-B*5701 testing is recommended because people carrying this allele have an increased risk of a serious hypersensitivity reaction. Patients with a previous hypersensitivity reaction to abacavir should not receive it. Triumeq Tablets Online Purchase in South Africa People searching for Triumeq tablets online in South Africa should obtain prescription medicines only through legitimate, appropriately regulated pharmaceutical channels. Availability, prescription requirements, import permissions and dispensing rules can differ according to local regulations. Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply and export enquiries from India. Buyers can contact the company for product availability, pack information, commercial quotations and export documentation, where applicable. Frequently Asked Questions What are Triumeq tablets used for? Triumeq tablets are used for the treatment of HIV-1 infection as part of an appropriate antiretroviral treatment plan. What are the ingredients in Triumeq? Triumeq contains abacavir 600 mg, dolutegravir 50 mg and lamivudine 300 mg in the standard tablet strength. How is Triumeq generally taken? The standard adult regimen is one tablet once daily, but treatment should always follow the prescription and instructions provided by the healthcare professional. It may be taken with or without food. Can everyone take Triumeq tablets? No. Certain medical conditions, previous medicine reactions, drug interactions and genetic factors can affect whether Triumeq is appropriate. Medical assessment is necessary before use. What important safety information should patients know? Abacavir-containing treatment can cause serious hypersensitivity reactions. Triumeq is also associated with important warnings involving hepatitis B, liver problems and lactic acidosis. Patients should seek medical advice promptly if concerning symptoms develop. Where can I enquire about Triumeq tablets in South Africa? For pharmaceutical supply enquiries, buyers in South Africa can contact Cordium Pharmaceuticals Pvt Ltd, an India-based pharmaceutical supplier and exporter, to discuss availability, documentation and applicable export requirements.

Ibrutinib Capsules are an oral targeted cancer medicine containing ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor. Ibrutinib is used under specialist medical supervision for certain blood cancers, including chronic lymphocytic leukaemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinaemia (WM), depending on the approved indication and the patient’s clinical condition. South African professional product information lists ibrutinib as a Schedule 4 medicine, meaning it requires appropriate prescription and medical oversight. Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical supplier and exporter offering support for international requirements involving oncology medicines. Customers and healthcare-related buyers in South Africa seeking Ibrutinib Capsules online can contact Cordium Pharmaceuticals for product availability, strength information, commercial quotations, and export-related requirements. Ibrutinib Capsules Product Description Ibrutinib works by inhibiting Bruton’s tyrosine kinase, a protein involved in B-cell receptor signalling. By interfering with this pathway, ibrutinib can help reduce the growth and survival of certain abnormal B cells. In South African approved product information, ibrutinib is indicated for specific adult patients with mantle cell lymphoma, chronic lymphocytic leukaemia, and Waldenström’s macroglobulinaemia. The exact indication, treatment combination and duration depend on the patient's diagnosis and the prescribing specialist's assessment. Ibrutinib Capsules for South Africa For buyers searching for Ibrutinib Capsules in South Africa, Cordium Pharmaceuticals can assist with international pharmaceutical supply enquiries from India. Product availability, packaging, strength, minimum order requirements, shipping arrangements and documentation should be confirmed before placing an order. Because Ibrutinib is a prescription oncology medicine, patients should not purchase or use it without a prescription and guidance from a qualified healthcare professional. South Africa's SAHPRA Online Medicines Directory provides information intended to help patients, consumers and healthcare professionals access reliable medicine information. Important Safety Information Ibrutinib may cause significant adverse effects and requires appropriate monitoring. Depending on the patient and treatment regimen, potential adverse reactions can include bleeding, infections, changes in blood-cell counts, diarrhoea, muscle or joint pain, hypertension and heart-related complications. The medicine can also interact with other medicines, so patients should provide their doctor with a complete list of medicines and supplements they are taking. The South African patient information advises patients to discuss their medical history and other medicines with their healthcare professional before treatment. Why Choose Cordium Pharmaceuticals? Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical sourcing from India with a focus on professional communication, product availability checks and export coordination. For Ibrutinib Capsules supply to South Africa, buyers can contact Cordium Pharmaceuticals to request current availability, pricing and shipping information. FAQs About Ibrutinib Capsules 1. What are Ibrutinib Capsules used for? Ibrutinib is used for certain blood cancers, including specific cases of CLL, MCL and Waldenström’s macroglobulinaemia. Treatment must be determined by an oncology specialist according to the approved indication and individual patient needs. 2. Can I buy Ibrutinib Capsules online in South Africa? Ibrutinib is a prescription oncology medicine. Online enquiries should be handled through legitimate pharmaceutical channels and in accordance with South African prescription and import requirements. Cordium Pharmaceuticals can provide information for international supply enquiries. 3. What strength of Ibrutinib Capsules is available? The available strength depends on the specific product and manufacturer. Buyers should contact Cordium Pharmaceuticals to confirm current strengths, packaging and availability before ordering. 4. Does Ibrutinib have side effects? Yes. Ibrutinib can cause side effects and serious adverse reactions. Patients should read the approved product information and immediately discuss concerning symptoms with their healthcare professional. 5. Can Ibrutinib be used without a prescription? No. Ibrutinib should only be used under the supervision of an appropriately qualified healthcare professional. It is not intended for self-medication. 6. How can South African buyers enquire about Ibrutinib Capsules from Cordium Pharmaceuticals? South African pharmaceutical buyers, distributors and eligible healthcare-related organisations can contact Cordium Pharmaceuticals Pvt Ltd with their product requirement. The company can then confirm availability, quotation, packaging and international shipping requirement